A Cure for Cancer? How CAR T-Cell Therapy is Revolutionizing Oncology
CAR-T therapy has been hailed as a cure for cancer, but what really is this…
10/09/2019 - 9 minutes
Lymphoma
The Best of the Rest: What Else Happened at this Year’s ASH Conference?
Last weekend marked the 59th Annual Meeting of the American Society of Hematology or ASH.…
11/12/2017 - 4 minutes
New Antibody-Drug Conjugate Offers Hope to Hard-to-Treat Cancer Patients
ADC Therapeutics has tested its antibody-drug conjugate technology in drug-resistant cancers, yielding encouraging results. Swiss biotech…
11/12/2017 - 3 minutes
This British Biotech Could Treat T-Cell Lymphoma without Leaving the Body Unprotected
Autolus has revealed a new strategy to treat T-cell lymphoma without harming healthy, protective T…
14/11/2017 - 2 minutes
The FDA Approves a Second CAR-T Therapy, Cheaper than Novartis’
Gilead's CAR-T cell therapy Yescarta has been approved by the FDA, making it the first…
19/10/2017 - 3 minutes
Swiss ADCs Show Impressive Responses for Lymphoma in Phase I
ADC Therapeutics has presented preliminary Phase I data in lymphoma patients suggesting its ADC technology…
16/06/2017 - 2 minutes
French Biotech Announces Positive Phase I Results in T-cell Lymphoma
Innate Pharma has released the safety and efficacy results of a Phase I trial testing…
15/06/2017 - 2 minutes
Update: MorphoSys Starts Phase III in Patients with Lymphoma
Update (02/06/2017): MorphoSys has successfully completed Phase II with MOR208 in combination with bendamustine and…
02/06/2017 - 3 minutes
FDA Speeds Up the Approval Process for Bayer’s New Lymphoma Drug
The FDA just granted Bayer priority review for copanlisib, a PI3K inhibitor which could be…
17/05/2017 - 2 minutes
Next-Gen Cancer Antibody Technology from Germany enters the Clinic
Apogenix' partner AbbVie has started the first clinical trial for an immuno-oncology candidate with the…
13/04/2017 - 2 minutes
Janssen Stops Phase II Trial for a Danish Blood Cancer Blockbuster
Janssen and Genmab will not proceed to evaluate daratumumab as a treatment for non-Hodgkin's lymphoma since it…
31/03/2017 - 2 minutes
Actelion gets EU Approval to Launch a Treatment for a Rare Skin Cancer
Actelion has received approval from the European Commission for Ledaga, a treatment to prevent the…
07/03/2017 - 2 minutes
